RFK Jr. Pulls Funding for mRNA Vaccines Due to Safety and Efficacy Concerns

HHS Decision on mRNA Vaccines

• 🎯 Barta, a division within HHS, has begun canceling 22 mRNA vaccine development investments totaling nearly $500 million.
• 💡 The decision stems from a review indicating mRNA vaccines perform poorly against viruses infecting the upper respiratory tract.
• ⚠️ A key concern is that mRNA vaccines, coding for only a small part of viral proteins, become ineffective with a single mutation, potentially encouraging new mutations and prolonging pandemics.

Scientific Rationale for Termination

• 🔬 HHS has determined that mRNA technology poses more risk than benefits for respiratory viruses after consulting experts from NIH and FDA.
• 🧬 The transcript highlights that the sheer amount of mRNA entering cells can cause biochemical havoc, disrupting protein metabolism, interfering with tumor suppressor genes, and damaging mitochondria.
• 📉 Meta-analysis studies consistently showed no benefit-to-risk ratio for mRNA vaccines, with some data suggesting it was more dangerous to take the vaccine than to contract COVID-19.

Criticism of Media and Public Figures

• 🗣️ The video criticizes mainstream media and public figures for spreading misinformation and ignoring facts about mRNA vaccine limitations.
• 🎭 Many in Hollywood and the media are accused of not wanting to discuss past decisions, preferring to move on from what is described as a "monstrous" experiment.
• 🤥 Some public figures are called out for changing their stance on vaccines once political power shifted, suggesting intentional deception.

Lack of Due Diligence and Transparency

• 🧐 Manufacturers are accused of not performing due diligence to ensure product safety before market release.
• 📜 Pfizer executives reportedly stated they did not conduct transmission or contraction tests before releasing the COVID vaccine, citing "the speed of science."
• ⏳ There are claims that companies sought to bury clinical trial data for up to 75 years, indicating a lack of transparency.

Adverse Events and Cost-Benefit Analysis

• ⚠️ Studies suggest that for every hospitalization prevented by mRNA vaccines in young adults, there were at least 18.5 serious adverse events.
• 📉 This cost-benefit analysis is presented as entirely against the use of mRNA platform vaccines for respiratory viruses.
• ❓ Questions are raised about the actual intention behind the shots if they were known to not prevent infection or transmission from the outset.

Broader Implications and Future Direction

• 🚀 HHS is shifting focus to developing safer, broader vaccine strategies, such as whole virus vaccines and novel platforms that are more resilient to viral mutations.
• 🚫 The termination of funding for mRNA vaccine research is seen as a potential end to the failed platform for these types of viruses.
• 📢 The video argues that this information is not being widely reported by mainstream, pharma-funded media, necessitating alternative platforms for truth dissemination.